Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06222710
Other study ID # JS-CT-2023-04
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 20, 2023
Est. completion date December 31, 2024

Study information

Verified date May 2024
Source Jaseng Medical Foundation
Contact Sunah Kim, KMD
Phone 82-42-1577-0007
Email tnsdk2648@jaseng.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to confirm the comparative effect and accuracy of ultrasound procedures by conducting a practical randomized controlled clinical study comparing patients (20 patients) with ultrasound-guided pharmacoacupuncture and patients (20 patients) without checking ultrasound images in 40 patients with whom complain of moderate or higher pain with 5 or higher NRS when stabilizing the shoulder joint.


Description:

This clinical study is conducted for the purpose of research, and it is a practical clinical study to confirm the comparative effect by comparing the strategy of treating patients with extreme myopathy (more than a month after the onset of symptoms) with ultrasound-guided acupuncture. Supraspinatus tendonopathy is the most common of rotator cuff tendonopathy, which occurs most frequently among shoulder diseases. Inflammation of joints, muscles, and tendons often means tendinitis. Pain within a few days of acute manifestation can be diagnosed as tendinitis, but if it is older than a few months, degenerative changes in tissues may be the main cause rather than inflammation, and in this case, it is called tendinosis. Clinically, the line between tendinitis and tendinosis is unclear, and it is collectively referred to as tendinopathy because it is a series of successive pathological processes. Rotator cuff refers to the four muscles: hypertrophy, hypertrophy, distal, and subscapular muscles, which play the most important role in rotator cuff. About 95% of the muscles, when they lift their arms to the side or forward, regression occurs in the hypertrophy due to the anatomical structure, and it progresses to rupture when continuous regression or strong trauma occurs. Due to the anatomical characteristics, conservative treatment is strong in that the pain area is persistent and the risk of recurrence is high when the arm is moved. Pharmacopuncture is a combination of acupuncture and drug therapy, which diagnoses a patient's constitution and disease condition and injects a certain amount of drugs extracted from specific herbal medicines into the treatment area to treat the disease. Ultrasound medical devices have the advantage of being able to perform high sensitivity, specificity, and dynamic tests, and being an inducer of not only diagnosis but also interventional treatment, allowing accurate procedures in real time without radiation exposure. In this study, 40 patients with external pain in their shoulders and symptoms lasting more than a month will be assigned to 20 patients who are treated with ultrasound-guided acupuncture and 20 patients who are treated with acupuncture using tactile acupuncture. The recruitment of patients will be conducted in non-competitive recruitment and will be conducted until the recruitment of all patients (40 patients) is completed. According to the schedule, patients will visit for a total of 12 treatments over a six-week period until the end of participation. After that, a total of two visits (weeks 7 and 13) will be made over a seven-week follow-up period.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2024
Est. primary completion date November 15, 2024
Accepts healthy volunteers No
Gender All
Age group 19 Years to 69 Years
Eligibility Inclusion Criteria: - Those between 19 and 70 years of age. - Those whose NRS (Numeric Rating Scale) of shoulder joint pain is 5 or higher and who complain of pain when abducting. - When supraspinatus tendinopathy is confirmed on MRI. - Those whose symptoms above last for more than 1 month. - Those who agree to participate in clinical research and provide written test subject consent. Exclusion Criteria: - For patients diagnosed with a specific serious disease that may cause shoulder pain (acute fracture, dislocation of the shoulder, complete rupture of rotator cuff, etc.) - For patients whose pain was caused by a condition other than the shoulder (tumor, fibromyalgia, rheumatoid arthritis, gout, cervical disc herniation, etc.) - In patients with other chronic conditions (such as stroke and myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with treatment effectiveness or interpretation of outcomes - Patients currently taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect their findings - Inadequate or unsafe medication: hemorrhagic disease, anticoagulant therapy, severe diabetic patients with risk of infection - Patients who have taken drugs that can affect pain such as non-steroidal anti-inflammatory drugs (NSAIDs) within the last week or have experienced acupuncture treatment - For patients who have received steroid injections within the last 3 months - In the case of pregnant women and in the case of planning to become pregnant or nursing - For patients within 6 months of shoulder surgery - If it has not been one month since the end of participation in other clinical studies, or if you are planning to participate in other clinical studies within six months from the date of selection and participate in other clinical studies during the follow-up period - If it is difficult to fill out a consent form to participate in the study - In cases where it is difficult for other researchers to participate in clinical research

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Pharmacoacupuncture with ultrasound guiding
Physician choose the adequate type and dose of pharmacoacupuncture and needle type with ultrasound guiding
Pharmacoacupuncture without ultrasound guiding
Physician choose the adequate type and dose of pharmacoacupuncture and needle type without ultrasound guiding

Locations

Country Name City State
Korea, Republic of Daejeon Jaseng Hospital of Korean Medicine Daejeon

Sponsors (1)

Lead Sponsor Collaborator
Jaseng Medical Foundation

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Shoulder pain numeric rating scale, NRS The intensity of spinal pain during the first week will be assessed using the NRS. In the NRS, patients choose a number from 0 to 10 that best describes their comfort (0 being no pain and 10 being the most comfortable they can imagine). Week 1,2,3,4,5,6,7,13
Secondary Shoulder Pain And Disability Index, SPADI The functional status of study subjects will be assessed using the SPADI questionnaire. SPADI is a 13-item questionnaire developed to assess the degree of disability related to shoulder pain. Each question is divided into 10 levels and consists of 5 questions in the pain evaluation section and 8 questions in the functional disability evaluation section. The higher the score, the more severe the disability. We will conduct an accredited Korean SPADI survey. Week 1,7,13
Secondary Range of motion, ROM Active and passive ROM will be measured before and after treatment to evaluate the degree of improvement after treatment. ROM is evaluated by measuring the angle between the subject's upper limb and an imaginary line drawn vertically from the ground in the maximum range of motion of the subject's shoulder joint in flexion, extension, abduction, adduction, external rotation, and internal rotation. If measurement is not possible due to pain, it will be recorded as UC. Week 1,2,3,4,5,6,7,13
Secondary Neer test Neer test is performed to evaluate the diagnostic significance before treatment and the degree of improvement after treatment. If measurement is not possible due to pain, it will be recorded as UC. Week 1,2,3,4,5,6,7,13
Secondary Empty can test Empty can test is performed to evaluate the diagnostic significance before treatment and the degree of improvement after treatment. If measurement is not possible due to pain, it will be recorded as UC. Week 1,2,3,4,5,6,7,13
Secondary Full can test Full can test is performed to evaluate the diagnostic significance before treatment and the degree of improvement after treatment. If measurement is not possible due to pain, it will be recorded as UC. Week 1,2,3,4,5,6,7,13
Secondary Hawkin's test Hawkin's test is performed to evaluate the diagnostic significance before treatment and the degree of improvement after treatment. If measurement is not possible due to pain, it will be recorded as UC. Week 1,2,3,4,5,6,7,13
Secondary EuroQol-5 Dimension, EQ-5D-5L EQ-5D-5L is a method of evaluating health status from various aspects and then indirectly calculating the quality weight of a specific health status using pre-assigned preference scores for each functional level. It is the most widely used among several indirect measurement methods. there is. The EQ-5D-5L consists of 5 questions. Each question includes mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Ask about the degree of depression, etc. Each item is weighted according to its level, and the preference score calculation equation is presented based on these weights and constants. Week 1,7,13
Secondary Patient Global Impression of Change, PGIC This is a method that allows the patient to subjectively evaluate the degree of improvement on a 7-level scale: 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse. Week 7,13
Secondary Muscle test To evaluate the degree of improvement in rotator cuff strength as shoulder stability is restored, the strength during external and internal rotation of the shoulder joint is compared with the healthy side. If measurement is not possible due to pain, it will be recorded as UC. Week 1,2,3,4,5,6,7,13
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06040853 - Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia? Phase 4
Not yet recruiting NCT05553496 - Assessment of Rituximab Therapeutic Response Versus Conventional Treatment Phase 2/Phase 3
Recruiting NCT05534802 - Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass N/A
Recruiting NCT04190537 - PARADOX - the Incidence of Paradoxical Reactions in Pediatric Patients Premedicated With Midazolam
Completed NCT03522532 - Dental Restorations Effect on Oxidative Status of the Gingival Crevicular Fluid N/A
Completed NCT03119454 - "Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice N/A
Unknown status NCT01614353 - Medication-taking Preferences & Practices of Patients With Chronic Conditions N/A
Completed NCT03714360 - The Effect of Tranexamic Acid. A Randomised Study of Patients Undergoing Elective Lumbar Spine Surgery. Phase 4
Recruiting NCT03352622 - Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis N/A
Recruiting NCT06288841 - Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in Gynecologic Laparoscopic Patients: A Randomized, Single-blind, Active-Controlled Clinical Study N/A
Not yet recruiting NCT04320277 - Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study. Phase 2/Phase 3
Completed NCT03359590 - Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients Phase 2
Not yet recruiting NCT03904303 - Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep Phase 1
Not yet recruiting NCT05453045 - Pharmacokinetics and Excretion of Albendazole and Its Metabolites in Saliva N/A
Completed NCT05591105 - Morphine Consumption in the Obese Patients
Completed NCT05428683 - Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery N/A
Enrolling by invitation NCT02985281 - Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients Phase 2/Phase 3
Not yet recruiting NCT03953287 - Pharmacokinetic Study of Paracetamol. Phase 1
Recruiting NCT03622047 - Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil N/A
Active, not recruiting NCT06324370 - Exploratory Pharmacokinetic Study of Virgin Coconut Oil (VCO) N/A